SPAC343.21 antibody is a research reagent designed to recognize and bind to the protein product of the SPAC343.21 gene locus in Schizosaccharomyces pombe (S. pombe), commonly known as fission yeast. This type of antibody falls within a category of scientific tools critical for investigating protein expression, localization, and function in cellular processes. While specific information about SPAC343.21 antibody is limited in the available search results, we can understand its potential significance by examining the broader context of S. pombe antibodies and their applications in molecular biology research.
The identification system "SPAC343.21" follows the standard nomenclature for S. pombe genes, where "SP" denotes Schizosaccharomyces pombe, "AC" indicates the specific chromosome (in this case, chromosome I), "343" refers to the cosmid or genomic fragment number, and "21" identifies the specific open reading frame (ORF) within that fragment. Similar naming conventions appear throughout the literature, as evidenced by references to SPAC343.19 and SPAC343.18, which are documented as encoding specific enzymes within the same genomic region .
Antibodies directed against S. pombe proteins serve as invaluable tools in cellular and molecular biology. These reagents enable researchers to visualize protein localization using immunofluorescence techniques, quantify protein expression through western blotting, isolate protein complexes via immunoprecipitation, and identify protein-protein interactions. Custom antibodies against specific S. pombe proteins, similar to what SPAC343.21 antibody would represent, are particularly valuable when investigating novel or poorly characterized gene products.
The S. pombe genome has been fully sequenced and contains approximately 5,000 genes distributed across three chromosomes. The SPAC343 region represents a specific segment on chromosome I. Available research indicates that neighboring genes in this region have diverse functions. For instance, SPAC343.19 appears to encode a type II enzyme according to the scientific literature . Similarly, SPAC343.18 has been mentioned in research related to SUMO-binding proteins and their regulatory functions .
The proteins encoded by genes in the SPAC343 region appear to participate in various cellular processes. For example, some proteins in this genomic neighborhood have demonstrated involvement in ubiquitin-like modifier (SUMO) pathways, which are critical for regulating protein function and cellular processes . This contextual information suggests potential avenues for investigation regarding SPAC343.21's biological role, though direct experimental evidence would be necessary to establish its specific function.
S. pombe antibodies are employed in diverse experimental approaches to elucidate protein function and cellular processes. In published research on related proteins, scientists have utilized antibodies to investigate essential cellular mechanisms including cytokinesis, septation, and cell division.
A key application of S. pombe antibodies involves determining subcellular localization of target proteins. For example, research on Pik1, a protein encoded by the SPAC22E12.16c locus, demonstrated its association with the Golgi apparatus and its appearance at the medial cell plane during late cytokinesis . Similar localization studies could potentially be conducted using SPAC343.21 antibody to determine where its target protein functions within the cell.
Antibodies facilitate the investigation of protein-protein interactions through co-immunoprecipitation experiments. Published research has utilized this approach to identify interactions between S. pombe proteins such as Pik1 and Cdc4, revealing important functional relationships . SPAC343.21 antibody could theoretically be employed in similar studies to identify binding partners of its target protein, providing insights into its biological role.
Another valuable application involves monitoring protein expression levels throughout the cell cycle. S. pombe serves as an excellent model organism for cell cycle studies due to its well-characterized division process. Antibodies against cell cycle-regulated proteins allow researchers to track expression patterns during different phases, potentially revealing regulatory mechanisms and functional significance.
When working with S. pombe antibodies like the hypothetical SPAC343.21 antibody, researchers must consider several methodological factors to ensure reliable results. These considerations extend to antibody validation, experimental controls, and optimization of protocols for specific applications.
Thorough validation is essential for antibodies against S. pombe proteins. Standard validation methods include:
Western blot analysis confirming specificity and absence of cross-reactivity
Immunofluorescence microscopy comparing wild-type cells with knockout mutants
Testing against recombinant proteins or peptides representing the target epitope
Comparing localization patterns with tagged versions of the target protein
These validation steps are critical for establishing confidence in experimental results obtained with any S. pombe antibody, including a potential SPAC343.21 antibody.
Research with S. pombe antibodies typically employs standard laboratory strains such as 972 (h-) or derivatives. Table 2 presents examples of S. pombe strains commonly used in antibody-based research, based on published studies.
| Strain Designation | Genotype | Common Applications |
|---|---|---|
| N2 | h+ leu1-32 ura4-D18 ade6-210 | General antibody studies, protein localization |
| N3 | h− leu1-32 ura4-D18 ade6-216 | General antibody studies, protein localization |
| N250 | h− his3-D1 leu1-32 ura4-D18 ade6-210 | Genetic modification studies |
| N1369 | h, pREP41+ Δpik1::ura4 ade6-M210 leu1-32 ura4-D18 -2XeGFP-pik1 | Fluorescent protein localization studies |
When conducting experiments with SPAC343.21 antibody, selecting appropriate strains and growth conditions would be crucial for obtaining meaningful results .
While specific information about SPAC343.21 is limited, contextual analysis of the SPAC343 region provides insights into potential biological functions. Genes in this region appear to be involved in diverse cellular processes, including those related to ubiquitin-like modification systems and enzymatic functions .
Comparative genomics approaches could yield valuable insights regarding SPAC343.21. By analyzing orthologous genes in related yeast species and examining conservation patterns, researchers could potentially infer functional information. This approach has proven successful for characterizing other S. pombe genes, including pik1, which shares homology with Saccharomyces cerevisiae PIK1 despite limited sequence conservation outside the lipid kinase domain (27% identity compared to 53% within the domain) .
Computational analysis of the SPAC343.21 protein sequence could reveal conserved domains and motifs associated with specific biochemical functions. Such predictions would guide experimental approaches using SPAC343.21 antibody to investigate potential enzymatic activities, binding capabilities, or structural roles.
KEGG: spo:SPAC343.21
SPAC343.21 is a gene in Schizosaccharomyces pombe that encodes a zinc finger protein involved in post-transcriptional regulation. Similar to characterized zinc finger proteins like zfs1, it likely contains CCCH tandem zinc finger domains that bind to specific mRNA sequences, particularly AU-rich elements (AREs) . Its significance stems from its potential role in regulating gene expression through mRNA binding and destabilization mechanisms comparable to vertebrate Tristetraprolin proteins, making it valuable for studying conserved post-transcriptional regulatory pathways .
For effective immunoblotting with SPAC343.21 antibodies, researchers should employ methodologies similar to those used for other S. pombe proteins. This includes cell lysis in extraction buffer (25 mM HEPES–KOH pH 7.5, 200 mM NaCl, 10% glycerol, 0.1% NP-40, 1 mM phenylmethylsulfonyl fluoride) supplemented with protease inhibitor cocktail . Double centrifugation (20 min at 7600 rpm followed by 30 min at 20,000 rpm) ensures extract clarity. For detection, horseradish peroxidase-conjugated secondary antibodies paired with an ECL chemiluminescence system provide optimal signal amplification and detection sensitivity .
To validate SPAC343.21 antibody specificity, researchers should implement multiple control strategies. First, compare protein detection in wild-type versus deletion mutant strains to confirm absence of signal in mutants. Second, perform immunoprecipitation followed by mass spectrometry to verify that the antibody captures the target protein. Third, conduct competitive binding assays with recombinant SPAC343.21 protein. Finally, test cross-reactivity with other zinc finger proteins such as zfs1 to ensure the antibody specifically recognizes SPAC343.21 and not related proteins with similar structural domains .
For optimal SPAC343.21 protein extraction from S. pombe, researchers should harvest approximately 1×10¹¹ exponentially growing cells and lyse them in extraction buffer containing 25 mM HEPES–KOH pH 7.5, 200 mM NaCl, 10% glycerol, and 0.1% NP-40, supplemented with 1 mM phenylmethylsulfonyl fluoride and a complete protease inhibitor cocktail . Double centrifugation (first at 7,600 rpm for 20 minutes, then at 20,000 rpm for 30 minutes) is crucial for removing cellular debris. This methodology preserves protein integrity while minimizing degradation, ensuring maximal recovery of intact SPAC343.21 protein for downstream applications such as immunoprecipitation and immunoblotting analyses .
When designing site-directed mutagenesis experiments for SPAC343.21 zinc finger domains, researchers should target conserved cysteine and histidine residues essential for zinc coordination. Based on established approaches for zinc finger proteins like zfs1, mutations should convert key cysteines to glycine (e.g., C370G) and histidines to isoleucine (e.g., H351I) . The experimental design should include:
PCR-based mutagenesis using systems like QuikChange (Stratagene)
Primer design with mutations centered within 25-35 nucleotide primers
Confirmation of mutations by dideoxy-chain terminator-based sequencing
Expression of both wild-type and mutant proteins
Comparative functional assays (e.g., RNA binding assays) to assess the impact of mutations
This approach enables precise evaluation of how specific residues contribute to RNA binding activity and protein function .
For rigorous immunoprecipitation experiments with SPAC343.21 antibodies, several essential controls must be included:
| Control Type | Implementation | Purpose |
|---|---|---|
| Negative Control | IP from deletion strain lacking SPAC343.21 | Evaluates non-specific binding |
| Input Control | Analysis of pre-IP lysate | Confirms target protein presence in starting material |
| IgG Control | Parallel IP with non-specific IgG | Identifies antibody class-specific background |
| Blocking Peptide | Competition with SPAC343.21 peptide | Verifies antibody specificity |
| Positive Control | IP of known interacting protein | Validates experimental system functionality |
Additionally, researchers should perform reverse immunoprecipitation if antibodies against potential interacting partners are available. Wash stringency should be empirically determined to balance between maintaining specific interactions and reducing background .
To characterize SPAC343.21 binding to target mRNAs using gel shift assays, researchers should follow a methodology similar to that established for other zinc finger RNA-binding proteins. Begin by generating recombinant SPAC343.21 protein, potentially as a fusion with maltose-binding protein (MBP) for improved solubility and purification . Next, design RNA oligonucleotide probes representing potential binding sites, particularly AU-rich elements (AREs), and end-label them with [³²P]pCp using T4 RNA ligase .
For the binding reaction, combine approximately 100 fmol of labeled probe (1×10⁴ cpm) with varying concentrations of purified protein (50-500 pmol) in appropriate binding buffer. After incubation, resolve complexes by non-denaturing polyacrylamide gel electrophoresis and visualize by phosphorimaging .
To establish binding specificity, researchers should:
Include competitive binding assays with unlabeled probes
Test mutant RNA probes with alterations in predicted binding motifs
Compare wild-type SPAC343.21 with zinc finger domain mutants (e.g., with C→G and H→I substitutions)
Determine binding affinity by performing serial dilutions of protein concentration
This comprehensive approach allows determination of sequence specificity, binding affinity, and critical residues involved in RNA recognition .
For comprehensive identification of SPAC343.21 target mRNAs, researchers should implement a multi-faceted transcriptomic approach. DNA microarray hybridization using platforms such as Yeast Genome 2.0 GeneChip (Affymetrix) can compare gene expression profiles between wild-type and SPAC343.21-deletion strains . Data normalization using MAS 5.0 followed by clustering of gene expression profiles enables identification of co-regulated genes .
To discover binding motifs, analyze the 800-bp upstream regions of differentially expressed genes using motif discovery software such as SPEXS . RNA immunoprecipitation followed by sequencing (RIP-seq) provides direct identification of bound mRNAs, while ribosome profiling can assess translational impacts of SPAC343.21 binding.
For validation, researchers should perform:
RT-qPCR confirmation of selected targets
Direct binding assays (gel shifts) with predicted target sequences
Reporter assays with wild-type and mutated binding sites
Analysis of mRNA stability in presence/absence of SPAC343.21
Data should be deposited in repositories such as NCBI GEO to ensure reproducibility and accessibility to the wider research community .
Differentiating between direct and indirect effects in SPAC343.21 knockout studies requires a systematic approach combining multiple methodologies. First, perform RNA immunoprecipitation to identify mRNAs directly bound by SPAC343.21 protein, followed by motif analysis to establish binding consensuses similar to approaches used for zinc finger proteins like zfs1 . Next, conduct time-course experiments using systems with conditional SPAC343.21 expression (such as the nmt promoter system used in S. pombe) to distinguish immediate versus delayed effects on target transcripts .
For definitive validation of direct targets, researchers should:
Create reporter constructs containing putative binding sites from target mRNAs
Test wild-type and mutated binding sites to assess specificity
Employ heterologous expression systems to isolate SPAC343.21 effects
Perform in vitro binding assays to confirm direct physical interactions
Use CRISPR-mediated mutation of binding sites in endogenous target mRNAs
Additionally, complementation studies with SPAC343.21 variants harboring mutations in RNA-binding domains can help distinguish which phenotypes depend specifically on RNA-binding activity versus potential protein-protein interaction functions .
When facing cross-reactivity issues with SPAC343.21 antibodies, researchers should implement a comprehensive optimization strategy. First, conduct epitope mapping to identify unique regions within SPAC343.21 that differ from related zinc finger proteins. Use this information to generate new antibodies against these distinctive epitopes or to affinity-purify existing polyclonal antibodies using epitope-specific columns .
For immunoblotting applications, increase blocking stringency using 5% BSA or milk powder and incorporate additional wash steps with higher detergent concentrations. Pre-absorption of antibodies with lysates from strains expressing related zinc finger proteins can remove cross-reactive antibodies while preserving SPAC343.21-specific ones .
For immunoprecipitation, consider using epitope-tagged versions of SPAC343.21 (GFP-tag or FLAG-tag) expressed from its native genomic locus, as this approach leverages highly specific commercial anti-tag antibodies . Validate specificity by mass spectrometry analysis of immunoprecipitated proteins to confirm target identity and assess potential cross-reactivity .
When interpreting conflicting results between different antibody-based detection methods for SPAC343.21, researchers must systematically evaluate several key factors. First, consider epitope accessibility differences across methods—immunoblotting detects denatured proteins, while immunoprecipitation and immunofluorescence detect native conformations, potentially explaining discrepancies . Second, assess method-specific technical variables such as fixation procedures, buffer compositions, and detection reagents that might differentially affect antibody performance .
To resolve conflicts, researchers should:
Compare monoclonal versus polyclonal antibodies recognizing different epitopes
Validate with orthogonal approaches (e.g., mass spectrometry, RNA-based detection)
Test antibody performance in knockout/knockdown controls for each method
Consider post-translational modifications that might be method-dependent
Evaluate protein-protein interactions that might mask epitopes in specific contexts
Creating a GFP or FLAG-tagged version of SPAC343.21 expressed from its native locus allows parallel detection with both tag-specific antibodies and SPAC343.21-specific antibodies, providing a powerful cross-validation approach .
Successful co-immunoprecipitation of SPAC343.21 with its interacting partners demands careful optimization of several critical parameters. Buffer composition represents the foremost consideration—use extraction buffer containing 25 mM HEPES–KOH pH 7.5, 200 mM NaCl, 10% glycerol, and 0.1% NP-40 as a starting point, but be prepared to adjust salt concentration (150-300 mM) and detergent type/concentration to preserve specific interactions .
Additional critical parameters include:
| Parameter | Recommendation | Rationale |
|---|---|---|
| Cell lysis conditions | Gentle mechanical disruption | Preserves protein complexes |
| Antibody quantity | Empirically determine optimal amount | Ensures efficient capture without excess |
| Incubation time | 2 hours at 4°C with gentle rotation | Balances binding efficiency and background |
| Wash stringency | Multiple washes with increasing stringency | Removes non-specific interactions |
| Elution method | Competitive elution with peptide (150 μg/mL) | Maintains complex integrity |
| Crosslinking | Consider reversible crosslinkers | Stabilizes transient interactions |
For RNA-dependent interactions, include control samples treated with RNase to distinguish direct protein-protein interactions from those mediated by RNA. When working with tagged versions, anti-FLAG M2 affinity gel provides excellent results for SPAC343.21-FLAG fusion proteins .
CRISPR-Cas9 technology offers powerful approaches for studying SPAC343.21 function in S. pombe. Researchers can implement precision genome editing to create clean knockouts, introduce point mutations in zinc finger domains, or generate fluorescent protein fusions at the endogenous locus. When designing guide RNAs, target unique sequences within SPAC343.21 to avoid off-target effects on related zinc finger genes .
For functional studies, CRISPR enables:
Precise mutation of predicted RNA-binding residues (analogous to the C370G and H351I mutations studied in zfs1)
Deletion or mutation of specific zinc finger domains to dissect their individual contributions
Introduction of auxin-inducible degron tags for temporal control of protein depletion
Base editing to introduce subtle modifications without double-strand breaks
CRISPRi approaches for transcriptional repression when complete knockout is lethal
For all CRISPR applications, researchers should verify editing precision through sequencing and validate functional consequences using RNA-binding assays comparable to those established for related zinc finger proteins .
To characterize the structural basis of SPAC343.21 interaction with target RNAs, researchers should employ a multi-technique approach beginning with computational homology modeling based on characterized zinc finger proteins like zfs1 . X-ray crystallography of recombinant SPAC343.21 protein domains complexed with target RNA oligonucleotides provides atomic-level interaction details, while nuclear magnetic resonance (NMR) spectroscopy offers insights into solution dynamics of these interactions.
For functional validation, implement systematic mutagenesis of both protein and RNA components:
Mutate conserved residues in zinc finger domains (cysteines and histidines essential for zinc coordination)
Create alanine scanning mutants across predicted RNA-contact surfaces
Design RNA probes with systematic mutations in binding motifs
Test binding affinity changes using quantitative gel shift assays or surface plasmon resonance
High-throughput approaches like RNA Bind-n-Seq can comprehensively map sequence preferences, while hydrogen-deuterium exchange mass spectrometry identifies RNA-induced conformational changes. Together, these techniques provide a detailed structural framework for understanding SPAC343.21-RNA recognition mechanisms .
Single-molecule imaging techniques offer unprecedented insights into SPAC343.21 dynamics in living S. pombe cells. To implement these approaches, researchers should generate fluorescent protein fusions (preferably with monomeric fluorophores like mNeonGreen) expressed from the endogenous locus to maintain native expression levels . For advanced analyses, consider multi-color imaging systems that simultaneously track SPAC343.21 and its mRNA targets using orthogonal labeling strategies.
Key single-molecule applications include:
Single-particle tracking to measure diffusion coefficients and residence times at potential binding sites
Fluorescence recovery after photobleaching (FRAP) to assess protein mobility in different cellular compartments
Fluorescence correlation spectroscopy (FCS) to analyze concentration and aggregation states
Single-molecule Förster resonance energy transfer (smFRET) to detect conformational changes upon RNA binding
Lattice light-sheet microscopy for extended 3D tracking with minimal phototoxicity
These approaches can reveal how SPAC343.21 dynamically associates with and dissociates from target mRNAs in response to cellular stresses or developmental cues. Analysis should employ specialized software to extract quantitative parameters like diffusion constants, binding rates, and complex stoichiometry .
SPAC343.21 belongs to the broader family of CCCH-type tandem zinc finger proteins that includes mammalian Tristetraprolin, an established mRNA-binding protein involved in transcript destabilization . Comparative functional analysis reveals that SPAC343.21 likely shares core RNA-binding mechanisms with other family members, specifically recognizing AU-rich elements (AREs) in target transcripts . Like its S. pombe relative zfs1, SPAC343.21 probably employs conserved cysteine and histidine residues to coordinate zinc ions, forming the structural foundation for sequence-specific RNA recognition .
Evolutionary analysis suggests functional conservation despite sequence divergence outside the zinc finger domains. Cross-species complementation studies could determine whether SPAC343.21 can rescue phenotypes in cells lacking other family members like zfs1 or mammalian TTP. These comparative approaches provide valuable insights into both conserved mechanisms and species-specific adaptations in post-transcriptional regulation mediated by CCCH zinc finger proteins .
To identify differential binding partners of SPAC343.21 compared to other zinc finger proteins, researchers should implement a multi-layered comparative proteomic strategy. Begin with parallel immunoprecipitation of epitope-tagged SPAC343.21 and related zinc finger proteins (e.g., zfs1), followed by mass spectrometry analysis . This approach directly compares interaction profiles under identical experimental conditions.
For comprehensive analysis, researchers should employ:
Quantitative proteomics using SILAC or TMT labeling to enable direct comparison of binding partner abundances
Reciprocal co-immunoprecipitation to validate key interactions
Proximity labeling methods (BioID or APEX) to capture transient or weak interactions
Domain-swapping experiments to identify regions responsible for differential interactions
Crosslinking mass spectrometry to map specific interaction interfaces
The methodological workflow should include RNase treatments to distinguish RNA-dependent from direct protein-protein interactions. Bioinformatic analysis of resulting datasets should focus on unique and shared interactors, with pathway enrichment analysis to identify biological processes specifically regulated by SPAC343.21 versus other zinc finger proteins .
To investigate post-translational modifications (PTMs) of SPAC343.21, researchers should implement a comprehensive experimental design that combines discovery, validation, and functional characterization approaches. Begin with mass spectrometry-based proteomics to identify endogenous modifications, using immunoprecipitated SPAC343.21-FLAG from various growth conditions and stress responses .
For systematic functional analysis, researchers should:
Generate phospho-mimetic (S/T to D/E) and phospho-dead (S/T to A) mutants of identified phosphorylation sites
Create lysine mutants (K to R) to block ubiquitination or SUMOylation at modified residues
Develop antibodies specific to key modifications for temporal analysis
Identify responsible kinases/modifying enzymes through candidate approaches or kinase inhibitor screens
Assess modification impacts on protein localization, stability, RNA-binding activity, and protein interactions
Compare these properties between wild-type and modification-site mutants using established assays like RNA gel shifts, immunoprecipitation, and fluorescence microscopy . For in vivo relevance, study modification patterns under diverse conditions such as oxidative stress, nutrient limitation, and cell cycle progression to understand dynamic regulation of SPAC343.21 function through its modification landscape.